953 related articles for article (PubMed ID: 24838134)
1. Balloon-expandable prostheses for transcatheter aortic valve replacement.
Ribeiro HB; Urena M; Allende R; Amat-Santos IJ; Rodés-Cabau J
Prog Cardiovasc Dis; 2014; 56(6):583-95. PubMed ID: 24838134
[TBL] [Abstract][Full Text] [Related]
2. A Strategy of Underexpansion and Ad Hoc Post-Dilation of Balloon-Expandable Transcatheter Aortic Valves in Patients at Risk of Annular Injury: Favorable Mid-Term Outcomes.
Tan JS; Leipsic J; Perlman G; Stub D; Dvir D; Hansson NC; Norgaard BL; Blanke P; Cheung A; Ye J; Thompson CR; Moss RR; Lauck S; Wood D; Webb J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1727-32. PubMed ID: 26476612
[TBL] [Abstract][Full Text] [Related]
3. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
[TBL] [Abstract][Full Text] [Related]
4. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J
JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
[TBL] [Abstract][Full Text] [Related]
5. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
[TBL] [Abstract][Full Text] [Related]
6. Self-expanding prostheses for transcatheter aortic valve replacement.
Kumar R; Latib A; Colombo A; Ruiz CE
Prog Cardiovasc Dis; 2014; 56(6):596-609. PubMed ID: 24838135
[TBL] [Abstract][Full Text] [Related]
7. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
Bapat V; Davies W; Attia R; Hancock J; Bolter K; Young C; Redwood S; Thomas M
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve.
Binder RK; Rodés-Cabau J; Wood DA; Mok M; Leipsic J; De Larochellière R; Toggweiler S; Dumont E; Freeman M; Willson AB; Webb JG
JACC Cardiovasc Interv; 2013 Mar; 6(3):293-300. PubMed ID: 23517842
[TBL] [Abstract][Full Text] [Related]
9. Incidence, predictive factors and haemodynamic consequences of acute stent recoil following transcatheter aortic valve implantation with a balloon-expandable valve.
Nombela-Franco L; Ribeiro HB; Urena M; Pasian S; Allende R; Doyle D; Delarochellière R; Delarochellière H; Laflamme L; Laflamme J; Jerez-Valero M; Côté M; Pibarot P; Larose E; Dumont E; Rodés-Cabau J
EuroIntervention; 2014; 9(12):1398-406. PubMed ID: 24064535
[TBL] [Abstract][Full Text] [Related]
10. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.
Abdel-Wahab M; Mehilli J; Frerker C; Neumann FJ; Kurz T; Tölg R; Zachow D; Guerra E; Massberg S; Schäfer U; El-Mawardy M; Richardt G;
JAMA; 2014 Apr; 311(15):1503-14. PubMed ID: 24682026
[TBL] [Abstract][Full Text] [Related]
11. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).
Hahn RT; Pibarot P; Webb J; Rodes-Cabau J; Herrmann HC; Williams M; Makkar R; Szeto WY; Main ML; Thourani VH; Tuzcu EM; Kapadia S; Akin J; McAndrew T; Xu K; Leon MB; Kodali SK
JACC Cardiovasc Interv; 2014 Jul; 7(7):781-9. PubMed ID: 25060022
[TBL] [Abstract][Full Text] [Related]
12. Edwards SAPIEN 3 valve.
Binder RK; Rodés-Cabau J; Wood DA; Webb JG
EuroIntervention; 2012 Sep; 8 Suppl Q():Q83-7. PubMed ID: 22995118
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.
Osten MD; Feindel C; Greutmann M; Chamberlain K; Meineri M; Rubin B; Mezody M; Ivanov J; Butany J; Horlick EM
Catheter Cardiovasc Interv; 2010 Mar; 75(4):475-85. PubMed ID: 19937781
[TBL] [Abstract][Full Text] [Related]
14. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves.
Toggweiler S; Wood DA; Rodés-Cabau J; Kapadia S; Willson AB; Ye J; Cheung A; Leipsic J; Binder RK; Gurvitch R; Freeman M; Thompson CR; Svensson LG; Dumont E; Tuzcu EM; Webb JG
JACC Cardiovasc Interv; 2012 May; 5(5):571-577. PubMed ID: 22625197
[TBL] [Abstract][Full Text] [Related]
17. Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis.
Kamperidis V; van Rosendael PJ; de Weger A; Katsanos S; Regeer M; van der Kley F; Mertens B; Sianos G; Ajmone Marsan N; Bax JJ; Delgado V
JACC Cardiovasc Interv; 2015 Apr; 8(5):670-7. PubMed ID: 25946438
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter aortic valve replacement using the Edwards SAPIEN transcatheter heart valves.
Huang PH; Eisenhauer AC
Cardiol Clin; 2013 Aug; 31(3):337-50. PubMed ID: 23931098
[TBL] [Abstract][Full Text] [Related]
19. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
20. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
